Xeljanz Trademark Details

Xeljanz was registered on Tuesday, February 14, 2012 and is currently owned by Pfizer Inc. under the registration number 4099367 . This mark is alive with a status of Registered. The last case file activity for this mark occured 12 years ago on Tuesday, February 14, 2012, according to the United State Patent & Trademark Office
Word Mark Xeljanz
Status Alive Registered 700 — Registered
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Serial Number 77688128
Registration Number 4099367
Status Date Tuesday, February 14, 2012
Filing Date Tuesday, February 14, 2012
Registration Date Tuesday, February 14, 2012
Attorney Jane Ungaro

Correspondent

Jane Ungaro
PFIZER INC.
150 E 42ND ST
NEW YORK NY 10017-5612

Case File Statements

Goods & Services Pharmaceutical preparations for the treatment of immunological and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations, namely, dermatological preparations

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Monday, March 16, 2009
First Use Anywhere Thursday, October 20, 2011
First Use In Commerce Thursday, October 20, 2011
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.